The Hamner Institutes for Health Sciences Release Podcast on Future of Bioscience Industry in China
Research Triangle Park, NC, November 12, 2009 --(PR.com)-- The Hamner Institutes for Health Sciences has announced the release of a podcast that reviews the explosive growth of China’s bioscience industry and discusses how an independent research institute in Research Triangle Park has established new collaborations with Chinese partners such as China Medical City and the Shanghai Center for Disease Control. In the podcast, Chief Business Officer Rick Williams provides an eyewitness perspective—based on four extensive trips to China in the past year—that addresses China’s scientific heritage, an overview of its science park strategy, and the importance of building win-win partnerships.
The podcast is available for download on The Hamner web site at: http://www.thehamner.org/news-and-events/hamner-in-the-news.html.
Dr. William Greenlee, Chief Executive Officer of The Hamner, and Williams recently completed three weeks of scientific and business development meetings in China, which included accompanying Governor Bev Perdue’s economic delegation to meet with senior officials in the Chinese Ministry of Commerce and Ministry of Science and Technology. They also conducted North Carolina bioscience seminars in Beijing and Shanghai that showcased some of North Carolina’s new cutting-edge technologies and partnerships in business and science. Speakers from China, as well as the North Carolina Biotechnology Center, University of North Carolina’s Center for Gene Therapy, Wake Forest Institute for Regenerative Medicine, and Syngenta, participated in the seminars. Governor Perdue provided opening comments in which she highlighted the importance of creating new opportunities for North Carolina and China to work together.
Quotes:
“Leaders in China’s science parks, companies, and government agencies are very interested in the new “dual gateway” bioscience model we have been developing at The Hamner to build a stronger bridge of technological innovation between North Carolina and China,” said Williams. “This podcast is the first in a series about China that describes how translational research and entrepreneurial business collaborations can enhance economic development and job opportunities.”
New Media Content:
The Hamner’s Twitter page
www.twitter.com/thehamner
Column by Rick Williams for WRAL’s Local Tech Wire – “China: The world’s next bioscience frontier”
http://localtechwire.com/business/local_tech_wire/news/blogpost/6240024/
YouTube clip – Hamner-China Medical City signing ceremony
http://www.youtube.com/watch?v=YFO2crFf6Ac
Hamner Video clip – Dr. Greenlee presentation at U.S. Chamber’s “China Business Forum”
http://www.thehamner.org/images/news-and-events/Hamner-China_Panel_WMV_V9.wmv
Details:
- During the first phase of The Hamner’s agreement with China Medical City, the Institute for International Drug Development will be established at The Hamner’s campus in Research Triangle Park (RTP), North Carolina, and will focus on preclinical drug development and compliance with FDA regulatory standards. After the partners validate research capabilities and new technologies at The Hamner campus, they will transfer them to China Medical City, a new life science park located in the Yangtze River Delta north of Shanghai.
About The Hamner Institutes for Health Sciences:
The Hamner Institutes for Health Sciences is a nonprofit research organization strategically located on a 56-acre campus in the heart of Research Triangle Park, North Carolina. For 35 years, scientists at The Hamner have conducted preeminent research in environmental health sciences and chemical risk assessment. Built upon an integrated systems-biology platform, The Hamner has broadened its mission to include translational research in biopharmaceutical safety, metabolic disorders, and oncology. The site also includes an Accelerator, which houses emerging companies and provides opportunities to develop collaborative research and educational programs with academia, industry, and government. The Hamner model for translational research and technology development integrates innovative science with business development while capitalizing on academic and industry partnerships. The Hamner supports the discovery of new, safer drugs and formation of new companies, which leads to research-based public health policy and enhanced economic development. For more information, visit www.thehamner.org or call (919) 558-1200.
Ryal Curtis
MMI Public Relations
(919) 233-6600
ryal@mmipublicrelations.com
http://twitter.com/MMIPR
www.mmipublicrelations.com
###
The podcast is available for download on The Hamner web site at: http://www.thehamner.org/news-and-events/hamner-in-the-news.html.
Dr. William Greenlee, Chief Executive Officer of The Hamner, and Williams recently completed three weeks of scientific and business development meetings in China, which included accompanying Governor Bev Perdue’s economic delegation to meet with senior officials in the Chinese Ministry of Commerce and Ministry of Science and Technology. They also conducted North Carolina bioscience seminars in Beijing and Shanghai that showcased some of North Carolina’s new cutting-edge technologies and partnerships in business and science. Speakers from China, as well as the North Carolina Biotechnology Center, University of North Carolina’s Center for Gene Therapy, Wake Forest Institute for Regenerative Medicine, and Syngenta, participated in the seminars. Governor Perdue provided opening comments in which she highlighted the importance of creating new opportunities for North Carolina and China to work together.
Quotes:
“Leaders in China’s science parks, companies, and government agencies are very interested in the new “dual gateway” bioscience model we have been developing at The Hamner to build a stronger bridge of technological innovation between North Carolina and China,” said Williams. “This podcast is the first in a series about China that describes how translational research and entrepreneurial business collaborations can enhance economic development and job opportunities.”
New Media Content:
The Hamner’s Twitter page
www.twitter.com/thehamner
Column by Rick Williams for WRAL’s Local Tech Wire – “China: The world’s next bioscience frontier”
http://localtechwire.com/business/local_tech_wire/news/blogpost/6240024/
YouTube clip – Hamner-China Medical City signing ceremony
http://www.youtube.com/watch?v=YFO2crFf6Ac
Hamner Video clip – Dr. Greenlee presentation at U.S. Chamber’s “China Business Forum”
http://www.thehamner.org/images/news-and-events/Hamner-China_Panel_WMV_V9.wmv
Details:
- During the first phase of The Hamner’s agreement with China Medical City, the Institute for International Drug Development will be established at The Hamner’s campus in Research Triangle Park (RTP), North Carolina, and will focus on preclinical drug development and compliance with FDA regulatory standards. After the partners validate research capabilities and new technologies at The Hamner campus, they will transfer them to China Medical City, a new life science park located in the Yangtze River Delta north of Shanghai.
About The Hamner Institutes for Health Sciences:
The Hamner Institutes for Health Sciences is a nonprofit research organization strategically located on a 56-acre campus in the heart of Research Triangle Park, North Carolina. For 35 years, scientists at The Hamner have conducted preeminent research in environmental health sciences and chemical risk assessment. Built upon an integrated systems-biology platform, The Hamner has broadened its mission to include translational research in biopharmaceutical safety, metabolic disorders, and oncology. The site also includes an Accelerator, which houses emerging companies and provides opportunities to develop collaborative research and educational programs with academia, industry, and government. The Hamner model for translational research and technology development integrates innovative science with business development while capitalizing on academic and industry partnerships. The Hamner supports the discovery of new, safer drugs and formation of new companies, which leads to research-based public health policy and enhanced economic development. For more information, visit www.thehamner.org or call (919) 558-1200.
Ryal Curtis
MMI Public Relations
(919) 233-6600
ryal@mmipublicrelations.com
http://twitter.com/MMIPR
www.mmipublicrelations.com
###
Contact
The Hamner Institutes for Health Sciences
Patty Briguglio
919-233-6600
www.mmipublicrelations.com
Patty Briguglio
919-233-6600
www.mmipublicrelations.com
Contact
Categories